GLAS supports acquisition financing for Valtecne

GLAS is pleased to have supported the financing arrangements relating to the acquisition of a controlling stake in Valtecne S.p.A., a leading Italian manufacturer of precision components for the MedTech sector, as part of a transaction that will lead to the company’s delisting from Euronext Growth Milan.

The GLAS team in Italy acted as Issuing Agent, Calculation Agent, Security Agent and Representative of Noteholders.

The transaction saw G Square Healthcare Private Equity, through its acquisition vehicle ValBlue BidCo, acquire approximately 82% of Valtecne’s share capital from the Mainetti family. Following completion of the acquisition, a mandatory public tender offer will be launched with the aim of delisting the company.

The transaction involved a number of advisers, including bureau Plattner on the corporate M&A aspects for G Square, PedersoliGattai on acquisition financing matters, and White & Case LLP advising Muzinich & Co. as lender within the private debt financing.

About Valtecne

Valtecne S.p.A. is an Italian company specialising in the manufacture of high-precision mechanical components and assembled devices for the medical technology industry. The company serves a range of international customers and has developed significant expertise in the production of complex components for highly regulated sectors.

About GLAS

Founded in 2011, GLAS is a leading independent global provider of debt administration services. As a non-lender and conflict-free firm, GLAS supports both private and public credit markets, distinguishing itself through its expertise, reliability and independence.

With over $920 billion of assets under administration, GLAS is headquartered in London and has an established international presence, with offices in the United States, France, Germany, Spain, Italy, the United Arab Emirates, Singapore, Hong Kong and Australia.

For further information, please contact: media@glas.agency.